Free Fatty Acid LC-MS Quantitation Without Extraction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for quantifying free fatty acids released from polysorbate hydrolysis in pharmaceutical formulations require an extraction step, which is time-consuming and limits high-throughput analysis.
Innovation Solution
A method for quantifying free fatty acids in pharmaceutical formulations without an extraction step, using liquid chromatography and mass spectrometry, with internal standards and calibration curves to ensure accuracy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If extraction step (e.g., solid phase extraction) is used before chromatography analysis, then free fatty acid quantification accuracy is improved, but analysis time increases and high-throughput capability is limited
Solution Approach 1:
The patent applies extraction principle by using liquid-liquid extraction with organic solvents (e.g., methyl tert-butyl ether, ethyl acetate) to separate free fatty acids from the pharmaceutical formulation matrix before chromatographic analysis. This extraction step concentrates the free fatty acids and removes interfering substances, thereby improving quantification accuracy while maintaining reasonable analysis time through optimized extraction protocols
Solution Approach 2:
The patent implements preliminary action by performing derivatization of free fatty acids with silylating agents (e.g., N,O-bis(trimethylsilyl)trifluoromethanesulfonamide) before chromatographic analysis. This preliminary chemical modification enhances the volatility and thermal stability of free fatty acids, improving their detectability and quantification accuracy in gas chromatography without significantly extending total analysis time
2Measurement precision
If extraction step is used before analysis, then free fatty acid detection sensitivity is improved, but device complexity and processing requirements increase
Solution Approach 1:
The patent uses derivatization reagents (silylating agents) as intermediaries to convert free fatty acids into more volatile and thermally stable derivatives. This intermediary chemical transformation enhances detection sensitivity in gas chromatography-mass spectrometry analysis while standardizing the processing procedure, thereby not significantly increasing overall device complexity despite the additional chemical step
3Reliability
If conventional quantification methods are used, then polysorbate degradation monitoring is achieved, but high-throughput analysis capability is limited
Solution Approach 1:
The patent employs parameter changes by optimizing chromatographic conditions (column temperature, flow rate, injection volume) and extraction parameters (solvent type, volume, extraction time) to reduce total analysis time. These parameter optimizations maintain reliable polysorbate degradation monitoring through accurate free fatty acid quantification while enabling higher throughput by reducing the time required for each analysis cycle
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables sensitive and efficient quantitation of free fatty acids, allowing for the detection of low levels of polysorbate degradation within a day and predicting long-term degradation in accelerated storage conditions.
Implementation Method 1
subjecting the formulation to liquid chromatography to separate the free fatty acids
Implementation Method 2
using a mass spectrometer to quantify the free fatty acids
Implementation Method 3
Enzymatic hydrolysis of polysorbate has been recognized as the primary route of polysorbate degradation in biotherapeutics formulations, resulting in the release of free fatty acids
Data Source
AI summary
The present invention generally pertains to methods of quantifying free fatty acids in a pharmaceutical formulation. In particular, the present invention pertains to a method of quantifying free fatty acids released from polysorbate hydrolysis in a pharmaceutical formulation comprising a pharmaceutical product, polysorbate and free fatty acids, using liquid chromatography-mass spectrometry, without the use of an extraction step.